I agree that this site is using cookies. You can find further informations here.
X
Antin, Nancy
42  results:
Search for persons X
?
1

ETCO2 Monitoring in High Risk Patients in the PACU: A Quali..:

Taylor, Helen ; Antin, Nancy ; Grandstrand, Julie...
Journal of PeriAnesthesia Nursing.  30 (2015)  4 - p. e18 , 2015
Link: https://doi.org/10.1016/..
 
?
2

Efficacy and Safety of Defibrotide to Treat Hepatic Veno-Oc..:

Kernan, Nancy ; Antin, Joseph ; Messinger, Yoav...
Clinical Lymphoma Myeloma and Leukemia.  17 (2017)  - p. S255 , 2017
Link: https://doi.org/10.1016/..
 
?
3

Timing of Initiation of Defibrotide Post-Diagnosis of Hepat..:

Richardson, Paul ; Smith, Angela ; Antin, Joseph...
Clinical Lymphoma Myeloma and Leukemia.  17 (2017)  - p. S276 , 2017
Link: https://doi.org/10.1016/..
 
?
4

Day+100 Survival and Safety Results from a Defibrotide Expa..:

Kernan, Nancy ; Smith, Angela ; Antin, Joseph...
Clinical Lymphoma Myeloma and Leukemia.  17 (2017)  - p. S276-S277 , 2017
Link: https://doi.org/10.1016/..
 
?
5

Favorable outcomes following allogeneic transplantation in ..:

Gooptu, Mahasweta ; Kim, Haesook T. ; Jacobsen, Eric...
Blood Advances.  7 (2023)  11 - p. 2309-2316 , 2023
Link: https://doi.org/10.1182/..
 
?
6

Tandem Autologous-Autologous versus Autologous-Allogeneic H..:

Giralt, Sergio ; Costa, Luciano J. ; Maloney, David...
Biology of Blood and Marrow Transplantation.  26 (2020)  4 - p. 798-804 , 2020
Link: https://doi.org/10.1016/..
 
?
7

Priorities for Improving Outcomes for Nonmalignant Blood Di..:

Levine, John E. ; Antin, Joseph H. ; Allen, Carl E....
Biology of Blood and Marrow Transplantation.  26 (2020)  5 - p. e94-e100 , 2020
Link: https://doi.org/10.1016/..
 
?
8

Genetic Predispositions, Management Strategies, and Clinica..:

Nikiforow, Sarah ; Berliner, Nancy ; Kim, Haesook T....
Biology of Blood and Marrow Transplantation.  25 (2019)  3 - p. S398 , 2019
Link: https://doi.org/10.1016/..
 
?
9

Contributors:

, In: Hematology,
Abdel-Wahab, Omar ; Abrahm, Janet L. ; Adams, Sharon... - p. vii-xxi , 2018
Link: https://doi.org/10.1016/..
 
?
10

Pooled Analysis of Day +100 Survival for Defibrotide-Treate..:

Richardson, Paul G. ; Smith, Angela R. ; Kernan, Nancy A....
Biology of Blood and Marrow Transplantation.  24 (2018)  3 - p. S317-S318 , 2018
Link: https://doi.org/10.1016/..
 
?
11

Defibrotide for the treatment of hepatic veno‐occlusive dis..:

Kernan, Nancy A. ; Richardson, Paul G. ; Smith, Angela R....
Pediatric Blood & Cancer.  65 (2018)  10 - p. , 2018
Link: https://doi.org/10.1002/..
 
?
12

Final results from a defibrotide treatment‐IND study for pa..:

Kernan, Nancy A. ; Grupp, Stephan ; Smith, Angela R....
British Journal of Haematology.  181 (2018)  6 - p. 816-827 , 2018
Link: https://doi.org/10.1111/..
 
?
13

Adults Receiving Defibrotide for the Treatment of Hepatic V..:

Richardson, Paul G. ; Antin, Joseph H. ; Giralt, Sergio A....
Biology of Blood and Marrow Transplantation.  24 (2018)  3 - p. S300-S301 , 2018
Link: https://doi.org/10.1016/..
 
?
14

Post Hoc Analysis of Defibrotide for Treatment of Hepatic V..:

Richardson, Paul G. ; Smith, Angela R. ; Triplett, Brandon M....
Biology of Blood and Marrow Transplantation.  23 (2017)  3 - p. S296-S297 , 2017
Link: https://doi.org/10.1016/..
 
?
15

Defibrotide for Patients with Hepatic Veno-Occlusive Diseas..:

Richardson, Paul G. ; Smith, Angela R. ; Triplett, Brandon M....
Biology of Blood and Marrow Transplantation.  23 (2017)  6 - p. 997-1004 , 2017
Link: https://doi.org/10.1016/..
 
1-15